A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A phase 1/2 trial of BGB-16673 in follicular lymphoma and hodgkin lymphoma, run by BeOne Medicines, now recruiting.
Overview
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies is a phase 1/2 interventional study registered as NCT05006716 by BeOne Medicines, with 645 participants planned, started 2021-09-13 and due to reach its primary completion in 2026-11. Interventions recorded: Tacabrutideg. Conditions listed: B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialTreatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
Shares BGB-16673, BeOne Medicines (formerly BeiGene), Mantle cell lymphoma, Follicular lymphoma.
- TrialGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Shares Mantle cell lymphoma, Follicular lymphoma, Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma.
- TrialA Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Shares Mantle cell lymphoma, Follicular lymphoma, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma.
- TermLugano classification / Ann Arbor staging
Shares Mantle cell lymphoma, Follicular lymphoma, Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- TrialA Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantl
Shares BeOne Medicines (formerly BeiGene), Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Hodgkin lymphoma.
- TrialT-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Shares Non-Hodgkin lymphoma (all types), Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- CollectionLymphoma Research Foundation (LRF)
Shares Mantle cell lymphoma, Follicular lymphoma, Hodgkin lymphoma, Diffuse large B-cell lymphoma.
- JournalHematological oncology
Shares Follicular lymphoma, Hodgkin lymphoma, Diffuse large B-cell lymphoma.